[1] |
Taxbro K, Hammarskjöld F, Thelin B, et al. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial[J]. Br J Anaesth, 2019, 122(6): 734-741.
|
[2] |
Hsu CC, Kwan GN, Evans-Barns H, et al. Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports[J]. Cochrane Database Syst Rev, 2016, 2016(8): CD008942.
|
[3] |
Niederhuber JE, Ensminger W, Gyves JW, et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment[J]. Surgery, 1982, 92(4): 706-712.
|
[4] |
Velioğlu Y, Yüksel A, Sınmaz E. Complications and management strategies of totally implantable venous access port insertion through percutaneous subclavian vein[J]. Turk Gogus Kalp Damar Cerrahisi Derg, 2019, 27(4): 499-507.
|
[5] |
Park S, Moon S, Pai H, et al. Appropriate duration of peripherally inserted central catheter maintenance to prevent central line-associated bloodstream infection[J]. PLoS One, 2020, 15(6): e0234966.
|
[6] |
Wu S, Huang J, Jiang Z, et al. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies[J]. BMC Cancer, 2016, 16(1): 747.
|
[7] |
Vinchurkar KM, Maste P, Togale MD, et al. Chemoport-associated complications and Its management[J]. Indian J Surg Oncol, 2020, 11(3): 394-397.
|
[8] |
余磊, 张英妹, 黄种文, 等. 经颈静脉及锁骨下静脉输液港植入术并发症的比较分析[J]. 当代医学, 2021, 27(3): 112-114.
|
[9] |
Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients[J]. CA Cancer J Clin, 2008, 58(6): 323-346.
|
[10] |
Aitken DR, Minton JP. The "pinch-off sign": a warning of impending problems with permanent subclavian catheters[J]. Am J Surg, 1984, 148(5): 633-636.
|
[11] |
Weekes AJ, Johnson DA, Keller SM, et al. Central vascular catheter placement evaluation using saline flush and bedside echocardiography[J]. Acad Emerg Med, 2014, 21(1): 65-72.
|